Cardiac Failure Review

Scope & Guideline

Exploring breakthroughs in cardiac failure management.

Introduction

Welcome to the Cardiac Failure Review information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cardiac Failure Review, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2057-7540
PublisherRADCLIFFE CARDIOLOGY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationCARD FAIL REV / Card. Fail. Rev.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIT F, BOURNE END BUSINESS PARK, BOURNE END, BUCKS SL8 5AS, ENGLAND

Aims and Scopes

The journal 'Cardiac Failure Review' is dedicated to advancing the understanding and management of heart failure through a comprehensive examination of its various aspects. The focus encompasses clinical, epidemiological, and therapeutic dimensions of heart failure, with an emphasis on innovative treatment strategies, diagnostic advancements, and patient-centered care.
  1. Heart Failure Management and Therapy:
    The journal emphasizes the latest developments in the management and therapeutic approaches to heart failure, including pharmacological treatments, device therapies, and patient education.
  2. Diagnostic Imaging and Biomarkers:
    A significant focus is placed on advancements in diagnostic imaging techniques and the identification of biomarkers that aid in the early detection, prognosis, and management of heart failure.
  3. Epidemiology and Public Health:
    Research published in the journal often addresses the epidemiological aspects of heart failure, including its global burden, demographic variations, and the impact of socioeconomic factors on patient outcomes.
  4. Multidisciplinary Approaches to Heart Failure Care:
    The journal highlights the importance of a multidisciplinary approach in heart failure management, integrating insights from cardiology, nursing, pharmacy, and public health.
  5. Emerging Therapies and Technologies:
    Innovations in treatment modalities, such as telemedicine and remote monitoring technologies, are explored to enhance patient management and outcomes.
The 'Cardiac Failure Review' has reflected emerging trends in heart failure research, highlighting new areas of focus that are gaining traction among researchers and clinicians. These trends indicate a shift towards more personalized, innovative, and comprehensive care models for heart failure patients.
  1. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF has surged, focusing on its unique challenges, treatment strategies, and the importance of this condition in the broader context of heart failure management.
  2. Telemedicine and Remote Monitoring:
    The integration of telemedicine and remote patient monitoring technologies has become increasingly prominent, particularly in light of the COVID-19 pandemic, emphasizing the need for innovative care solutions.
  3. Diversity and Health Disparities:
    There is a growing emphasis on understanding and addressing health disparities in heart failure care, particularly among minority populations, highlighting the importance of equitable healthcare access.
  4. Biomarkers and Personalized Medicine:
    The exploration of biomarkers for early detection and personalized treatment strategies is on the rise, reflecting a shift towards tailored therapy based on individual patient profiles.
  5. Multimodality Imaging:
    The use of multimodality imaging techniques to enhance diagnosis and treatment planning in heart failure is emerging as a critical theme, showcasing advancements in imaging technologies.

Declining or Waning

Over recent years, certain themes within the 'Cardiac Failure Review' have shown a decline in publication frequency, suggesting a shift in focus or a saturation of research in those areas. This decline may reflect evolving priorities in heart failure research or advancements that have rendered some topics less critical.
  1. Traditional Pharmacotherapy:
    While traditional pharmacotherapy for heart failure remains important, there has been a noticeable decline in articles focused on older classes of medications, as newer therapies and treatment strategies gain prominence.
  2. Basic Pathophysiological Studies:
    Research centered on basic pathophysiological mechanisms of heart failure has decreased, possibly due to a growing emphasis on clinical applications and translational research.
  3. Generalized Management Guidelines:
    Publications that reiterate general heart failure management guidelines without new insights or data have diminished, as the field moves towards more personalized and patient-specific treatment approaches.

Similar Journals

HEART FAILURE REVIEWS

Transforming Heart Failure Understanding Through Collaboration
Publisher: SPRINGERISSN: 1382-4147Frequency: 6 issues/year

HEART FAILURE REVIEWS is a premier academic journal published by Springer, dedicated to the dynamic field of cardiology and cardiovascular medicine. With an impressive Q1 ranking in 2023, the journal stands as a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments in heart failure management and research. Covering a broad spectrum of topics, including innovative therapies, epidemiology, and pathophysiology of heart failure, it fosters an environment for interdisciplinary collaboration. The journal is indexed with an ISSN of 1382-4147 and an E-ISSN of 1573-7322, ensuring widespread dissemination of knowledge. Although it does not currently offer open access options, its rigorous peer-review process guarantees high-quality content that contributes significantly to the scientific community. Established in 1996 and running through 2024, HEART FAILURE REVIEWS continues to be a leading platform for advancing understanding and treatment of heart conditions, making it an indispensable resource for all stakeholders in cardiac health.

KARDIOLOGIYA

Illuminating the Path to Cardiovascular Excellence
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

Netherlands Heart Journal

Exploring Innovations in Heart Health and Disease Management
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

TEXAS HEART INSTITUTE JOURNAL

Advancing Cardiovascular Knowledge, One Heartbeat at a Time.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Korean Circulation Journal

Advancing Cardiovascular Knowledge, One Study at a Time.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Heart Failure Clinics

Advancing Heart Health Through Innovative Research
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7136Frequency: 4 issues/year

Heart Failure Clinics, published by Elsevier Science Inc, stands at the forefront of research and clinical practice in the rapidly evolving field of cardiology and cardiovascular medicine. With an ISSN of 1551-7136, this prestigious journal has established a reputation for high-quality peer-reviewed articles, offering critical insights into heart failure management, innovative therapies, and health care strategies. Ranked in the Q2 quartile for cardiology and cardiovascular medicine and recognized in the Q1 quartile for miscellaneous medicine as of 2023, it reflects a significant impact on both clinical and academic communities, holding a commendable position in the 73rd percentile of its category according to Scopus rankings. Since its inception in 2005, this journal has continuously been a vital resource for researchers, healthcare professionals, and students aiming to enhance their understanding of heart failure. Although it does not offer full open access options, the depth and relevance of its content make it indispensable for anyone engaged in heart health research and practice. Located in the heart of New York, at 230 Park Ave, STE 800, it aims to foster knowledge exchange and promote advancements in cardiovascular care until its converged years in 2024.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Transforming Insights into Clinical Excellence
Publisher: WILEYISSN: 0742-2822Frequency: 12 issues/year

ECHOCARDIOGRAPHY: A Journal of Cardiovascular Ultrasound and Allied Techniques is a premier scholarly publication committed to advancing the field of cardiovascular imaging through the dissemination of high-quality research and clinical studies. Published by Wiley, this journal has been a vital resource since its inception in 1984, aiming to bridge the gap between ultrasound techniques and clinical practice over its converged years extending to 2024. With an ISSN of 0742-2822 and an E-ISSN of 1540-8175, the journal is indexed in notable databases and holds a respectable standing in its field, reflected in its Q3 rankings in Cardiovascular Medicine, Miscellaneous Medicine, and Radiology for 2023. Though currently not open access, the journal strives to provide valuable insights and innovative techniques to researchers, professionals, and students alike, fostering a deeper understanding of echocardiography and its impact on patient care. Located in the United States, the journal continues to serve as a cornerstone for contemporary cardiovascular research and education, ensuring that the latest advancements and practices are readily accessible to the medical community.

Hellenic Journal of Cardiology

Empowering Heart Health Through Innovative Research
Publisher: ELSEVIERISSN: 1109-9666Frequency: 6 issues/year

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

Frontiers in Cardiovascular Medicine

Advancing Cardiovascular Knowledge for a Healthier Tomorrow.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

IJC Heart & Vasculature

Connecting Clinicians and Researchers in Cardiovascular Medicine
Publisher: ELSEVIER IRELAND LTDISSN: Frequency: 4 issues/year

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.